Short answer
Lucid Diagnostics Inc. (LUCD) filed its Q3 2026 10-Q quarterly report on Nov 12, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $1M (down 0.7% year over year) with net income of −$7M.
Q3 2026 key financials · XBRL
- Revenue
- $1M
- −0.7% YoY · −18.5% QoQ
- Net income
- −$7M
- +35.8% YoY · +42.9% QoQ
- Operating margin
- -1021.3%
- EPS (diluted)
- −$0.02
- +71.4% YoY · +71.4% QoQ
Source: XBRL data from the Lucid Diagnostics Inc. (LUCD) Q3 2026 10-Q on SEC EDGAR. USD.
Lucid Diagnostics Inc. Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $1.2M, flat versus $1.2M in Q3 2025
- Gross margin negative 16.7% versus negative 41.7% YoY, based on revenue and cost of revenue
- Sales and marketing worst-performing expense line: $5.3M, up from $4.3M YoY
- Cash $18.0M at September 30, 2026; operating cash use $38.9M for nine months
- Series C preferred offering generated $15.0M gross proceeds; going-concern doubt and recurring losses remain near-term headwinds
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Lucid Diagnostics Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.